Journal article
Efficacy of parenteral formulations of desmopressin in the treatment of bleeding disorders: A systematic review
Abstract
INTRODUCTION: Desmopressin (DDAVP) is a proven therapy for bleeding disorders; however, the therapeutic efficacy of different parenteral formulations has never been systematically analyzed. This study investigated whether subcutaneous (SC) DDAVP provides equivalent hemostatic efficacy to intravenous (IV) desmopressin, particularly in patients with mild to moderate bleeding tendencies from hemophilia A (HA) or von Willebrand disease (vWD).
Authors
Sreeraman S; McKinlay S; Li A; Crowther M; Motalo O
Journal
Thrombosis Research, Vol. 213, , pp. 16–26
Publisher
Elsevier
Publication Date
May 2022
DOI
10.1016/j.thromres.2022.02.019
ISSN
0049-3848